PAF-induced coronary vasoconstriction in rat hearts is mediated by the release of leukotrienes and prostaglandins, with leukotrienes modulating the production of cyclo-oxygenase products.
No takes yet. Share an insight, caveat, or question.
Should not inform clinical coronary vasospasm management; leaves open leukotriene-prostaglandin modulation for human translation studies.
Hu et al. (1991) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: